Visx
This article was originally published in The Gray Sheet
Executive Summary
Firm's Star S2 and S3 ActiveTrak ophthalmic excimer laser systems gain expanded FDA approval for variable spot scanning to achieve larger treatment zones for myopia, the firm says. The technique ablates 51% more surface area, up to 8 mm, to provide "additional flexibility when pupil size is a concern," Visx explains. Upgrade software kits to enable the feature will be made available to physicians certified by Visx' education department